BioQ10 SA
High bioavailability of CoQ10 is achieved by original composite of BioQ10 (CoQ10) and specific soy protein.
BioQ10 SA bioavailability study in rats
After administration of BioQ10 SA, plasma CoQ10 level is markedly increased as compared BioQ10 only.
*Single dose test by rat : 100mg/kg, n = 3
Excellent flexibility of dosage form
The high bioavailability is attained without any kind of oils. This new development is able to be used with powder form. It is possible to take a wide variety dosage forms including simple hard capsules, soft capsules, tablet, chewable, granules.
Putative mechanism of improvement of intestinal absorption
Our specific soy protein supports the emulsification of CoQ10. The micelles of emulsified CoQ10 enhance the intestinal absorption of CoQ10. This mechanism suggests that BioQ10 SA may be applicable to achieve the high performance of CoQ10.
Specification and Safety data sheet of BioQ10 SA
| Item | Bio Q10 SA |
|---|---|
| Appearance | Yellow to orange powder |
| CoenzymeQ10 content (%) | 78.0~82.0 |
| Non-tapped density | 0.25~0.4g/ml |
| Tapped density | 0.35~0.5g/ml |
| Water content (%) | < 2.0 |
| Heavy metals (ppm) | < 10 |
| Lead (Pb) (ppm) | < 0.1 |
| Microbial Limit Test (cfu/g) | < 1,000 |
| Total Coliforms | Negative |
| Salmonella | Negative |
| Fungi | Negative |
| Ingredients | Coenzyme Q10 (80%), Soy Protein (18%), Silica Dioxide (2%) |
| Shelf life | 3 years from date of manufacturing |
| Packing | Carton box (10kg) |
| Acute Toxicity Test | LD50 (Oral): Rats, sexed > 5,000mg/kg |
|---|---|
| Skin irritancy test | Negative |
| Mutagenicity test (Ames Test) | Results of reverse mutation test using bacteria (4 strains of salmonella, 1 strain of coli bacteria) were negative. |
